Sharma E, Dahal S, Sharma P, Bhandari A, Gupta V, Amgai B, Dahal S. The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study. Journal of clinical medicine research. 2018;10(8):636-640.

Article  Google Scholar 

Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Adrenocortical Carcinoma. Endocrine Reviews. 2014;35(2):282-326.

Article  CAS  Google Scholar 

Gallinger B, Druker H, Gill AJ, Wasserman JD, Kim RH. The adrenal gland: an evolution of the roles of genetic counsellors and medical geneticists in endocrine cancers. Diagnostic Histopathology. 2016;22(3):108-122.

Article  Google Scholar 

Kim D, Murvelashvili N, Hamidi O, Jia L. Adrenal Cortical Carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical Carcinoma. International journal of surgical pathology. 2022:10668969221117246.

Else T. Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Molecular and cellular endocrinology. 2012;351(1):66-70.

Article  CAS  Google Scholar 

Else T, Lerario AM, Everett J, Haymon L, Wham D, Mullane M, Wilson TL, Rainville I, Rana H, Worth AJ, Snyder NW, Blair IA, McKay R, Kilbridge K, Hammer G, et al. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. Eur J Endocrinol. 2017;177(5):439-444.

Article  CAS  Google Scholar 

Juhlin CC, Bertherat J, Giordano TJ, Hammer GD, Sasano H, Mete O. What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics. Endocr Pathol. 2021;32(1):102-133.

Article  CAS  Google Scholar 

Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, Papotti MG. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors. Endocr Pathol. 2022;33(1):155-196.

Article  CAS  Google Scholar 

Xie C, Tanakchi S, Raygada M, Davis JL, Del Rivero J. Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation. J Endocr Soc. 2019;3(1):284-290.

Article  Google Scholar 

El Ghorayeb N, Grunenwald S, Nolet S, Primeau V, Côté S, Maugard CM, Lacroix A, Gaboury L, Bourdeau I. First case report of an adrenocortical carcinoma caused by a BRCA2 mutation. Medicine (Baltimore). 2016;95(36):e4756.

Article  Google Scholar 

Torres MB, Diggs LP, Wei JS, Khan J, Miettinen M, Fasaye GA, Gillespie A, Widemann BC, Kaplan RN, Davis JL, Hernandez JM, Rivero JD. Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. Cancer Genet. 2021;256-257:21-25.

Article  Google Scholar 

Landwehr LS, Schreiner J, Appenzeller S, Kircher S, Herterich S, Sbiera S, Fassnacht M, Kroiss M, Weigand I. A novel patient-derived cell line of adrenocortical carcinoma shows a pathogenic role of germline MUTYH mutation and high tumour mutational burden. Eur J Endocrinol. 2021;184(6):823-835.

Article  CAS  Google Scholar 

Assié G, Letouzé E, Fassnacht M, Jouinot A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K, René-Corail F, Elarouci N, Sbiera S, Kroiss M, Allolio B, Waldmann J, et al. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics. 2014;46(6):607-612.

Article  Google Scholar 

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, et al. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell. 2016;29(5):723-736.

Article  CAS  Google Scholar 

Warren MB, Torres-Cabala CA, Turner ML, Merino MJ, Matrosova VY, Nickerson ML, Ma W, Linehan WM, Zbar B, Schmidt LS. Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissues. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2004;17(8):998–1011.

Reese E, Sluzevich J, Kluijt I, Teertstra HJ, De Jong D, Horenblas S, Ryu J, Birt-Hogg-Dubé Syndrome, in Cancer Syndromes, D.L. Riegert-Johnson, L.A. Boardman, and T. Hefferon, Editors. 2009, National Center for Biotechnology Information (US): Bethesda (MD).

Woodford MR, Andreou A, Baba M, van de Beek I, Di Malta C, Glykofridis I, Grimes H, Henske EP, Iliopoulos O, Kurihara M, Lazor R, Linehan WM, Matsumoto K, Marciniak SJ, Namba Y, et al. Seventh BHD international symposium: recent scientific and clinical advancement. Oncotarget. 2022;13:173-181.

Article  Google Scholar 

Kalloniati E, Antoniades E, Athanasouli F. Birt-Hogg-Dubé Syndrome and coexistence with adrenocortical carcinoma. Hippokratia. 2021;25(1):49-49.

CAS  Google Scholar 

Ramsingh J,Watson C. Oncocytoma of the adrenal gland in Birt-Hogg-Dube syndrome. BMJ case reports. 2018;2018.

Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T. An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome. Clinical endocrinology. 2014;80(6):925-7.

Article  Google Scholar 

Kunogi M, Kurihara M, Ikegami TS, Kobayashi T, Shindo N, Kumasaka T, Gunji Y, Kikkawa M, Iwakami S-i, Hino O, Takahashi K, Seyama K. Clinical and genetic spectrum of Birt-Hogg-Dube syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature. Journal of medical genetics. 2010;47(4):281–7.

Juszczak A, Halliday D, Mihai R, Ali A. A large adrenal tumour as a phenotypic manifestation of the Birt-Hogg-Dube syndrome. in Endocrine Abstracts. 2011.

Mandelker D,Ceyhan-Birsoy O. Evolving Significance of Tumor-Normal Sequencing in Cancer Care. Trends in Cancer. 2020;6(1):31-39.

Article  CAS  Google Scholar 

Malone ER, Saleh RR, Yu C, Ahmed L, Pugh T, Torchia J, Bartlett J, Virtanen C, Hotte SJ, Hilton J, Welch S, Robinson A, McCready E, Lo B, Sadikovic B, et al. OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing. Curr Oncol. 2019;26(5):e618-e623.

Article  CAS  Google Scholar 

Pittaway JFH,Guasti L. Pathobiology and genetics of adrenocortical carcinoma. J Mol Endocrinol. 2019;62(2):R105-R119.

Article  CAS  Google Scholar 

Pinto EM, Chen X, Easton J, Finkelstein D, Liu Z, Pounds S, Rodriguez-Galindo C, Lund TC, Mardis ER, Wilson RK, Boggs K, Yergeau D, Cheng J, Mulder HL, Manne J, et al. Genomic landscape of paediatric adrenocortical tumours. Nat Commun. 2015;6:6302.

Article  CAS  Google Scholar 

Mete O, Gucer H, Kefeli M, Asa SL. Diagnostic and Prognostic Biomarkers of Adrenal Cortical Carcinoma. Am J Surg Pathol. 2018;42(2):201-213.

Article  Google Scholar 

Brondani VB, Lacombe AMF, Mariani BMP, Montenegro L, Soares IC, Bezerra-Neto JE, Tanno FY, Srougi V, Chambo JL, Mendonca BB, Almeida MQ, Zerbini MCN, Fragoso MCBV. Low Protein Expression of both ATRX and ZNRF3 as Novel Negative Prognostic Markers of Adult Adrenocortical Carcinoma. Int J Mol Sci. 2021;22(3).

Ramirez Reyes JMJ, Cuesta R, Pause A. Folliculin: A Regulator of Transcription Through AMPK and mTOR Signaling Pathways. Front Cell Dev Biol. 2021;9:667311.

Article  Google Scholar 

De Martino MC, Feelders RA, Pivonello C, Simeoli C, Papa F, Colao A, Pivonello R, Hofland LJ. The role of mTOR pathway as target for treatment in adrenocortical cancer. Endocr Connect. 2019;8(9):R144-R156.

Article  Google Scholar 

Liang J,Mills GB. AMPK: a contextual oncogene or tumor suppressor? Cancer Res. 2013;73(10):2929-35.

Article  CAS  Google Scholar 

Batisse-Lignier M, Sahut-Barnola I, Tissier F, Dumontet T, Mathieu M, Drelon C, Pointud JC, Damon-Soubeyrand C, Marceau G, Kemeny JL, Bertherat J, Tauveron I, Val P, Martinez A, Lefrançois-Martinez AM. P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model. Oncogene. 2017;36(31):4445-4456.

Article  CAS  Google Scholar 

Juhlin CC, Goh G, Healy JM, Fonseca AL, Scholl UI, Stenman A, Kunstman JW, Brown TC, Overton JD, Mane SM, Nelson-Williams C, Bäckdahl M, Suttorp AC, Haase M, Choi M, et al. Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma. J Clin Endocrinol Metab. 2015;100(3):E493-502.

Article  CAS  Google Scholar